{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:37:51Z","timestamp":1782981471993,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gastrointestinal (GI) symptoms are common in individuals with Cystic Fibrosis (CF). International research has highlighted that GI care for this group of patients is lacking. Gastroenterology services to CF clinics across Australasia are yet to be examined. This study aimed to describe the current service delivery model and identify areas for improvement that may lead to positive patient outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>CF clinicians (dietitians, clinical nurse consultants, respiratory consultants), gastroenterologists (GE), and patients or their carers from Australia and New Zealand (NZ) were surveyed online to gather their opinions on CF gastroenterology services provided in their region. Data were analysed using descriptive statistics (frequencies and percentages). Likert scale questions were analysed by grouping responses 1\u20135 and 6\u201310, presented alongside the median and interquartile range (IQR). Mann\u2013Whitney <jats:italic>U<\/jats:italic> and chi-square tests were used to look at differences between stakeholder groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and fifty-six health professionals and 172 patients or their carers completed the survey. Results showed that the current GI model of care is predominantly a publicly funded service delivered outside of CF clinic time. GE are largely not integrated into the CF team and report a lack of training opportunities. There is a higher level of dissatisfaction with the current service model in NZ than Australia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>No stakeholder group deemed the current CF gastroenterology service model as adequate, leaving opportunity for transformations in this field. Ideally this study will invigorate the need for promotion and integration of GI services that would ultimately benefit the whole CF community.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1322941","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T10:31:33Z","timestamp":1702636293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: a multi-stakeholder assessment of patients' and professionals\u2019 perspectives"],"prefix":"10.3389","volume":"11","author":[{"given":"Tamarah E.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angharad","family":"Vernon-Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Y.","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19748","DOI":"10.1038\/s41598-022-24374-4","article-title":"Survival of people with cystic fibrosis in Australia","volume":"12","author":"Ruseckaite","year":"2022","journal-title":"Sci Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0174463","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PloS one"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101788","DOI":"10.1016\/j.bpg.2022.101788","article-title":"Digestive outcomes in cystic fibrosis","author":"Ley","year":"2022","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/17474124.2018.1502663","article-title":"Gastrointestinal pathophysiology and nutrition in cystic fibrosis","volume":"12","author":"Ratchford","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European cystic fibrosis society standards of care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J Cyst Fibros"},{"key":"B9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"B10","doi-asserted-by":"publisher","first-page":"A178","DOI":"10.1136\/gutjnl-2020-bsgcampus.338","article-title":"P264 variation in specialist gastroenterology services for patients with cystic fibrosis in the UK","volume":"70","author":"FitzPatrick","year":"2021","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1590\/S0212-16112012000200005","article-title":"Multidisciplinary care in cystic fibrosis: a clinical-nutrition review","volume":"27","author":"Haack","year":"2012","journal-title":"Nutr Hosp"},{"key":"B12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jpc.13921","article-title":"Practical approach to the gastrointestinal manifestations of cystic fibrosis","volume":"54","author":"Bolia","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"877118","DOI":"10.3389\/fphar.2022.877118.","article-title":"Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2023","journal-title":"J Cyst Fibros"},{"key":"B15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1479972316631135","article-title":"Pain and its clinical associations in individuals with cystic fibrosis: a systematic review","volume":"13","author":"Lee","year":"2016","journal-title":"Chron Respir Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.jcf.2017.06.009","article-title":"Approach to chronic abdominal pain in cystic fibrosis","volume":"16","author":"Lusman","year":"2017","journal-title":"J Cyst Fibros"},{"key":"B18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/01.ajp.0000210996.45459.76","article-title":"Effect of disease-related pain on the health-related quality of life of children and adolescents with cystic fibrosis","volume":"22","author":"Palermo","year":"2006","journal-title":"Clin J Pain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0225004","DOI":"10.1371\/journal.pone.0225004","article-title":"Assessing gastro-intestinal related quality of life in cystic fibrosis: validation of PedsQL GI in children and their parents","volume":"14","author":"Boon","year":"2019","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcf.2022.10.006","article-title":"Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis","volume":"2","author":"Moshiree","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B21","volume-title":"Cystic fibrosis standards of care, Australia","author":"Bell","year":"2008"},{"key":"B22","year":""},{"key":"B23","article-title":"Nutrition guidelines for cystic fibrosis in Australia and New Zealand","author":"Saxby","year":"2017"},{"key":"B24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/resp.12764","article-title":"Physiotherapy for cystic fibrosis in Australia and New Zealand: a clinical practice guideline","volume":"21","author":"Button","year":"2016","journal-title":"Respirology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/resp.12227","article-title":"Australian Standards of care for cystic fibrosis-related diabetes","volume":"19","author":"Middleton","year":"2014","journal-title":"Respirology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/ncp.10605","article-title":"Variations in nutrition practices in cystic fibrosis: a survey of the DIGEST program","volume":"36","author":"Shaikhkhalil","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"B27","year":""},{"key":"B28","article-title":"On behalf of the Australian cystic fibrosis data registry","author":"Ahern","year":"2021"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1322941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T10:31:37Z","timestamp":1702636297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1322941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":28,"alternative-id":["10.3389\/fped.2023.1322941"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1322941","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"article-number":"1322941"}}